News – Page 147 – Endpoints News

Foresite Capital closes $900M sixth fund, backing the likes of Xaira and IPO hopeful Alumis

11 months ago

Ultragenyx touts Phase 2 data for Mereo-partnered rare bone disorder drug as Phase 3 gets underway

11 months ago

China biotech ban does not make the cut as add-on to defense spending bill

11 months ago

Corrected: Life science company Agilent cuts over 180+ employees in California

11 months ago

Avidity’s early-phase data for rare muscle disease drug spur registrational plans

11 months ago

Updated: FDA funding would stay flat under House appropriations bill

11 months ago

Lilly exec points to Medicare as more pay full list price for Zepbound than Mounjaro

11 months ago

NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book

11 months ago

Sanders pushes subpoena vote to force testimony of Novo Nordisk exec on GLP-1 prices

11 months ago

Verily gets into the GLP-1 business with new program to manage cardiac and metabolic conditions

11 months ago

ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio

11 months ago

Pivoting to ‘ADC-like’ approach, Versant-backed startup gets $90M Series C

11 months ago

ARCH backs lab instrument company that wants to help demystify how cells talk to each other

11 months ago

BIO's new CEO takes a patriotic pivot to win back Congress, pushing industry to rethink China relationship

11 months ago

Oscar stakes its future on companies dumping worker health benefits

11 months ago

New obesity biotech Syntis Bio launches with early-stage alternative to GLP-1s

11 months ago

Exclusive: Auxilius raises $10M to help biotechs manage clinical trial finances

11 months ago

Ipsen and Genfit secure FDA thumbs up for rare liver disease asset

11 months ago

FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay

11 months ago

Paxlovid did not beat placebo in Stanford-led long Covid study

12 months ago

GSK stands by Orange Book patents that FTC has asked to rescind

12 months ago

Kyowa Kirin invests $530M in first manufacturing site in North America

12 months ago

FDA establishes new meeting type to advise on drug safety technology

12 months ago

Teladoc names insurance executive as new CEO

12 months ago

First page Previous page 144 145 146147148 149 150 Next page Last page